.svg){kind=small}
In Lisbon, ESC Preventive Cardiology 2025 brings together experts dedicated to enhancing preventive measures in cardiology. Attendees will gain insights into evidence-based approaches, community health strategies, and innovative technologies improving patient outcomes. Our team will present research addressing key challenges in prevention and discuss collaboration opportunities to drive impactful solutions. Let’s meet to explore shared goals in advancing preventive care.
-min.jpg)
.jpg)
Latest news
Richmond Appoints Lisa Campbell as Director of Regulatory Strategy
April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read moreVon Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol
April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read moreEvents
Swiss Biotech Day 2025
5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event
